Samsara BioCapital’s Surrozen, Inc. Warrant SRZNW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81K | Hold |
99,999
| – | – | ﹤0.01% | 29 |
|
|
2025
Q1 | $3K | Hold |
99,999
| – | – | ﹤0.01% | 37 |
|
|
2024
Q4 | $2.14K | Hold |
99,999
| – | – | ﹤0.01% | 43 |
|
|
2024
Q3 | $1.03K | Hold |
99,999
| – | – | ﹤0.01% | 42 |
|
|
2024
Q2 | $1.66K | Hold |
99,999
| – | – | ﹤0.01% | 40 |
|
|
2024
Q1 | $3.02K | Hold |
99,999
| – | – | ﹤0.01% | 39 |
|
|
2023
Q4 | $1.94K | Hold |
99,999
| – | – | ﹤0.01% | 41 |
|
|
2023
Q3 | $4.11K | Hold |
99,999
| – | – | ﹤0.01% | 41 |
|
|
2023
Q2 | $5.52K | Hold |
99,999
| – | – | ﹤0.01% | 47 |
|
|
2023
Q1 | $10K | Hold |
99,999
| – | – | ﹤0.01% | 56 |
|
|
2022
Q4 | $5.51K | Hold |
99,999
| – | – | ﹤0.01% | 54 |
|
|
2022
Q3 | $18K | Hold |
99,999
| – | – | ﹤0.01% | 55 |
|
|
2022
Q2 | $19K | Buy |
+99,999
| New | +$19K | 0.01% | 56 |
|